Elixxer Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ELIXF research report →
Companywww.elixxer.com
Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cannabis-related businesses, which are fully licensed for cultivation, production, and/or sale of medical and specialty cannabis and cannabis-derived products in the pharmaceutical sector.
- CEO
- Karim Mecklai
- IPO
- 2017
- HQ
- Montreal, QC, CA
Price Chart
Valuation
- Market Cap
- $23.35M
- P/E
- -0.13
- P/S
- 0.00
- P/B
- -0.05
- EV/EBITDA
- -116.37
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 29.22%
- ROIC
- 380.09%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-3,865,565 · -200604.31%
- EPS
- $-0.34 · -169900.00%
- Op Income
- $-665,378
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.10
- 52W Low
- $0.00
- 50D MA
- $0.03
- 200D MA
- $0.04
- Beta
- -0.54
- Avg Volume
- 4.35K
Get TickerSpark's AI analysis on ELIXF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ELIXF Coverage
We haven't published any research on ELIXF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ELIXF Report →